These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15779384)

  • 21. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of the limb fat to trunk fat ratio with markers of cardiometabolic risk in elderly men and women.
    Saunders TJ; Davidson LE; Janiszewski PM; Després JP; Hudson R; Ross R
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1066-70. PubMed ID: 19561143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference.
    Magni P; Liuzzi A; Ruscica M; Dozio E; Ferrario S; Bussi I; Minocci A; Castagna A; Motta M; Savia G
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):189-96. PubMed ID: 15670195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucose intolerance in visceral fat syndrome].
    Matsuzawa Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():746-51. PubMed ID: 12238130
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome.
    Opie LH
    Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease].
    Kozłowska A; Kowalska I
    Endokrynol Pol; 2006; 57(6):626-32. PubMed ID: 17253436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Insulin resistance syndrome, visceral fat syndrome].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():792-8. PubMed ID: 9434566
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertension as a cardiometabolic risk.
    Srikanth S; Deedwania P
    Indian Heart J; 2010; 62(5):394-401. PubMed ID: 23189879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipotoxicity].
    Ebihara K; Nakao K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():165-70. PubMed ID: 21766590
    [No Abstract]   [Full Text] [Related]  

  • 34. [A worldwide consensus definition for the metabolic syndrome].
    Rev Panam Salud Publica; 2005 Dec; 18(6):451-4. PubMed ID: 16536931
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathogenesis and etiology of cardiovascular disease: role of insulin resistance].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():163-8. PubMed ID: 17458212
    [No Abstract]   [Full Text] [Related]  

  • 36. [Visceral fat].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():699-705. PubMed ID: 12355836
    [No Abstract]   [Full Text] [Related]  

  • 37. [Risk of cardiovascular diseases in relation to insulin resistance: the Tanno-Sobetsu study].
    Saitoh S
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():59-63. PubMed ID: 17458195
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid overload and overflow: metabolic trauma and the metabolic syndrome.
    Unger RH
    Trends Endocrinol Metab; 2003 Nov; 14(9):398-403. PubMed ID: 14580758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic syndrome: precursor to diabetes and cardiovascular diseases].
    Arsenault P; Cloutier L; Longpré S
    Perspect Infirm; 2012; 9(3):30-4. PubMed ID: 23451420
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic syndrome: convergence of metabolic diseases based on obesity and dysfunction of adipose tissue].
    Masuzaki H; Tanaka T; Nakao K
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():17-22. PubMed ID: 17458189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.